IDEXX Laboratories (NASDAQ:IDXX) Downgraded by StockNews.com to Hold
StockNews.com cut shares of IDEXX Laboratories (NASDAQ:IDXX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. IDXX has been the subject of a number of other reports. Barclays increased their price objective on IDEXX Laboratories from $481.00 to $520.00 and gave the company […]
StockNews.com cut shares of IDEXX Laboratories (NASDAQ:IDXX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. IDXX has been the subject of a number of other reports. Barclays increased their price objective on IDEXX Laboratories from $481.00 to $520.00 and gave the company […]
